Sugarloaf Wealth Management, LLC Bluebird Bio, Inc. Transaction History

Sugarloaf Wealth Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 20, 2021	SELL	$18.04 - $22.09 $9,525 - $11,663	-528 Closed	0 $0
Q1 2021 Apr 19, 2021	SELL	$16.59 - $33.89 $7,830 - $15,996	-472 Reduced 47.2%	528 $19,000
Q4 2020 Feb 03, 2021	BUY	$27.5 - $37.92 $27,500 - $37,920	1,000 New	1,000 $43,000
Q1 2020 Apr 15, 2020	SELL	$26.16 - $63.5 $1,569 - $3,810	-60 Closed	0 $0
Q4 2019 Jan 29, 2020	BUY	$46.96 - $61.67 $2,817 - $3,700	60 New	60 $5,000

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $28.5M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Sugarloaf Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sugarloaf Wealth Management, LLC with notifications on news.